<DOC>
	<DOCNO>NCT01187238</DOCNO>
	<brief_summary>The purpose study verify role add cisplatin chemotherapy intensity-modulated radiotherapy ( IMRT ) stage II nasopharyngeal carcinoma .</brief_summary>
	<brief_title>The Value Concurrent Chemoradiotherapy Stage II Nasopharyngeal Carcinoma</brief_title>
	<detailed_description>Clinical Stage II nasopharyngeal carcinoma consist T2N0M0 , T1N1M0 , T2N1M0 three subgroup , data come conventional radiotherapy era show prognosis three subgroup different , N1 group suffer distant metastasis N0 group , literature show combined chemotherapy radiotherapy stage II patient improve treatment result . Intensity-modulated radiotherapy ( IMRT ) widely use technique treatment nasopharyngeal carcinoma , preliminary result show IMRT improve quality life nasopharyngeal salivary gland preservation . Compared IMRT alone IMRT plus cisplatin concurrent chemotherapy treatment stageII nasopharyngeal carcinoma , hope confirm whether stage II ( subgroup ) nasopharyngeal carcinoma benefit concurrent chemoradiotherapy .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>pathological confirm squamous cell carcinoma , WHO IIIII type , clinical stage II ( UICC 7th edition , 2009 ) Karnovsky performance score &gt; 70 first course radiotherapy , without radiotherapy chemotherapy history head neck cancer . anticipated life span 6 month Hemoglobin &gt; 120g/L , WBC &gt; 4.0x10*9/L , Plt &gt; 100x10*9/L liver renal function 1.25 normal upper limit write consent information cancer history chemotherapy history radiotherapy history head neck surgery history ( exclusion lymph node biopsy ) evidence show distant metastasis cancer severe medical comorbidity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Nasopharyngeal carcinoma</keyword>
	<keyword>Stage II</keyword>
	<keyword>Intensity-modulated radiotherapy</keyword>
	<keyword>Concurrent chemoradiotherapy</keyword>
	<keyword>Cisplatin</keyword>
</DOC>